Literature DB >> 32405955

Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications.

Mario Manto1,2, Nicolas Dupre3, Marios Hadjivassiliou4, Elan D Louis5, Hiroshi Mitoma6, Marco Molinari7, Aasef G Shaikh8, Bing-Wen Soong9,10,11, Michael Strupp12, Frank Van Overwalle13, Jeremy D Schmahmann14.   

Abstract

The current worldwide severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic that causes coronavirus disease 2019 (COVID-19) has brought some medical systems to the brink of collapse. This crisis is also negatively impacting the care of patients with non-COVID-19 conditions, including those with cerebellar ataxia (CA). Older patients with CA and those with immune-mediated ataxias on immunosuppressive medication are potentially at high risk of developing serious complications of the infection, although it is also possible that immunosuppressive agents may provide a defense against cytokine storm. This has implications for even greater attention to preventing contracting the disease through physical distancing and/or isolation. The CA patient population is also at higher risk because of the neurological complexities of their underlying disorder and the comorbid medical illnesses that often accompany the genetic ataxias. As the disruption of social patterns and healthcare delivery in response to the crisis continues, interruption of rehabilitation, speech and language therapy, and face-to-face consultations threatens to have a negative impact on the course and well-being of CA patients. Mental and physical health is also potentially at greater risk because the prevailing uncertainty and anxiety may be superimposed upon cerebellum-specific neuropsychological challenges. We identify and review some of the short- and long-term consequences of this global pandemic for the community of ataxia patients and their families and for the clinical and academic neurologists/ataxiologists caring for these patients. This includes the recognition that telemedicine has emerged as a principle means of caregiver-patient contact and that neurological manifestations of COVID-19 including those specific to cerebellar neurobiology are increasingly recognized and will require close surveillance and monitoring. This COVID-19 Cerebellum Task Force consensus provides some guidance on how we may approach this uncertain time and consider preparing for the new realities we face in CA patient care once this acute crisis has passed.

Entities:  

Keywords:  COVID-19; Cerebellar ataxia; Cerebellum; SARS-CoV-2

Mesh:

Year:  2020        PMID: 32405955      PMCID: PMC7220536          DOI: 10.1007/s12311-020-01139-1

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  15 in total

1.  Long-term effects of coordinative training in degenerative cerebellar disease.

Authors:  Winfried Ilg; Doris Brötz; Susanne Burkard; Martin A Giese; Ludger Schöls; Matthis Synofzik
Journal:  Mov Disord       Date:  2010-10-15       Impact factor: 10.338

2.  Longitudinal study of cognitive and psychiatric functions in spinocerebellar ataxia types 1 and 2.

Authors:  Roberto Fancellu; Dominga Paridi; Chiara Tomasello; Marta Panzeri; Anna Castaldo; Silvia Genitrini; Paola Soliveri; Floriano Girotti
Journal:  J Neurol       Date:  2013-12       Impact factor: 4.849

3.  The cerebellar cognitive affective syndrome.

Authors:  J D Schmahmann; J C Sherman
Journal:  Brain       Date:  1998-04       Impact factor: 13.501

4.  Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.

Authors:  Ling Mao; Huijuan Jin; Mengdie Wang; Yu Hu; Shengcai Chen; Quanwei He; Jiang Chang; Candong Hong; Yifan Zhou; David Wang; Xiaoping Miao; Yanan Li; Bo Hu
Journal:  JAMA Neurol       Date:  2020-06-01       Impact factor: 18.302

5.  A global clinical measure of fitness and frailty in elderly people.

Authors:  Kenneth Rockwood; Xiaowei Song; Chris MacKnight; Howard Bergman; David B Hogan; Ian McDowell; Arnold Mitnitski
Journal:  CMAJ       Date:  2005-08-30       Impact factor: 8.262

6.  Virological assessment of hospitalized patients with COVID-2019.

Authors:  Roman Wölfel; Victor M Corman; Wolfgang Guggemos; Michael Seilmaier; Sabine Zange; Marcel A Müller; Daniela Niemeyer; Terry C Jones; Patrick Vollmar; Camilla Rothe; Michael Hoelscher; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Rosina Ehmann; Katrin Zwirglmaier; Christian Drosten; Clemens Wendtner
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

Review 7.  Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence.

Authors:  Beth Russell; Charlotte Moss; Gincy George; Aida Santaolalla; Andrew Cope; Sophie Papa; Mieke Van Hemelrijck
Journal:  Ecancermedicalscience       Date:  2020-03-27

Review 8.  Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis.

Authors:  Israel Júnior Borges do Nascimento; Nensi Cacic; Hebatullah Mohamed Abdulazeem; Thilo Caspar von Groote; Umesh Jayarajah; Ishanka Weerasekara; Meisam Abdar Esfahani; Vinicius Tassoni Civile; Ana Marusic; Ana Jeroncic; Nelson Carvas Junior; Tina Poklepovic Pericic; Irena Zakarija-Grkovic; Silvana Mangeon Meirelles Guimarães; Nicola Luigi Bragazzi; Maria Bjorklund; Ahmad Sofi-Mahmudi; Mohammad Altujjar; Maoyi Tian; Diana Maria Cespedes Arcani; Dónal P O'Mathúna; Milena Soriano Marcolino
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241

9.  Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.

Authors:  Saiju Jacob; Srikanth Muppidi; Amanda Guidon; Jeffrey Guptill; Michael Hehir; James F Howard; Isabel Illa; Renato Mantegazza; Hiroyuki Murai; Kimiaki Utsugisawa; John Vissing; Heinz Wiendl; Richard J Nowak
Journal:  J Neurol Sci       Date:  2020-03-25       Impact factor: 3.181

10.  Psychological crisis intervention during the outbreak period of new coronavirus pneumonia from experience in Shanghai.

Authors:  Xixi Jiang; Lili Deng; Yuncheng Zhu; Haifeng Ji; Lily Tao; Li Liu; Daoliang Yang; Weidong Ji
Journal:  Psychiatry Res       Date:  2020-02-28       Impact factor: 3.222

View more
  10 in total

1.  Early Impact of the COVID-19 Pandemic on Outpatient Neurologic Care in Hawai'i.

Authors:  Julie Crocker; Keke Liu; Maiya Smith; Max Nakamoto; Catherine Mitchell; Ena Zhu; Enze Ma; Frances Tiffany Morden; Ariel Chong; Nicholas Van; Nong Dang; Pat Borman; Enrique Carrazana; Jason Viereck; Kore Kai Liow
Journal:  Hawaii J Health Soc Welf       Date:  2022-01

2.  Development and Validation of a Deep Learning Model to Quantify Interstitial Fibrosis and Tubular Atrophy From Kidney Ultrasonography Images.

Authors:  Ambarish M Athavale; Peter D Hart; Mathew Itteera; David Cimbaluk; Tushar Patel; Anas Alabkaa; Jose Arruda; Ashok Singh; Avi Rosenberg; Hemant Kulkarni
Journal:  JAMA Netw Open       Date:  2021-05-03

Review 3.  How COVID-19 will boost remote exercise-based treatment in Parkinson's disease: a narrative review.

Authors:  Agnes Langer; Lucia Gassner; Anna Flotz; Sebastian Hasenauer; Jakob Gruber; Laurenz Wizany; Rochus Pokan; Walter Maetzler; Heidemarie Zach
Journal:  NPJ Parkinsons Dis       Date:  2021-03-08

4.  Impacts of the COVID-19 Pandemic on the Mental Health and Motor Deficits in Cuban Patients with Cerebellar Ataxias.

Authors:  Yasmany González-Garcés; Yennis Domínguez-Barrios; Arianna Zayas-Hernández; Aldo A Sigler-Villanueva; Nalia Canales-Ochoa; María O Hernández Oliver; María B Ramírez-Bautista; Alberto Caballero-Laguna; Eduardo Arrufat-Pie; Frank J Carrillo-Rodes; Jacqueline Medrano-Montero; Yanela Rodríguez-Álvarez; Osiel Gámez-Rodríguez; Leonardo A Guerra-Rondón; Osvaldo Aguilera-Batista; Yaimee Vazquez-Mojena; Roberto Rodríguez-Labrada; Luis Velázquez-Pérez
Journal:  Cerebellum       Date:  2021-03-25       Impact factor: 3.847

5.  Advantages and disadvantages of telemedicine during the COVID-19 pandemic era among physicians in Taif, Saudi Arabia.

Authors:  Adnan A Mubaraki; Aeshah D Alrabie; Afnan K Sibyani; Raghad S Aljuaid; Ameerah S Bajaber; Murad A Mubaraki
Journal:  Saudi Med J       Date:  2021-01       Impact factor: 1.484

6.  2 Years into the Pandemic: What Did We Learn About the COVID-19 and Cerebellum?

Authors:  Aasef G Shaikh; Mario Manto; Hiroshi Mitoma
Journal:  Cerebellum       Date:  2022-02       Impact factor: 3.648

Review 7.  COVID-19 and Physical Activity Behaviour in People with Neurological Diseases: A Systematic Review.

Authors:  Zuhal Abasıyanık; Merve Kurt; Turhan Kahraman
Journal:  J Dev Phys Disabil       Date:  2022-02-01

Review 8.  Challenges to infection control in early communication intervention: A scoping review.

Authors:  Bilqees Achmat; Berna Gerber
Journal:  S Afr J Commun Disord       Date:  2022-08-03

9.  COVID-19 pandemic and the international classification of functioning in multiple system atrophy: a cross-sectional, nationwide survey in Japan.

Authors:  Koshiro Haruyama; Michiyuki Kawakami; Ichiro Miyai; Shuko Nojiri; Toshiyuki Fujiwara
Journal:  Sci Rep       Date:  2022-08-19       Impact factor: 4.996

10.  Impact of SARS-CoV-2 Infection in Spinocerebellar Ataxia 12 Patients.

Authors:  Inder Singh; Vishnu Swarup; Sunil Shakya; Vikash Kumar; Deepika Gupta; Roopa Rajan; Divya M Radhakrishnan; Mohammed Faruq; Achal Kumar Srivastava
Journal:  Mov Disord       Date:  2021-10-07       Impact factor: 10.338

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.